期刊文献+

疫苗接种人群和安慰剂人群肠道病毒A71型基因特征分析 被引量:1

Genetic Characteristics of Enterovirus A71 Isolated from Subjects Receiving Enterovirus A71 Inactivated Vaccine or Placebo
原文传递
导出
摘要 目的 分析比较健康人群接种肠道病毒A71型(Enterovirus A71,EV-A71)灭活疫苗和安慰剂后EV-A71感染的基因特征。方法 按照1∶1配对的病例对照研究,统计比较接种组和安慰剂组人群中EV-A71导致相关疾病流行病学差异;利用Sequencher 5.0和MEG5.0等生物信息学软件分析不同组别的EV-A71的VP1区核苷酸和氨基酸差异,获得不同人群中EV-A71的分子流行病学特征。结果 本研究共有接种组病例13例(0.3%),安慰剂组106例(2.1%);EV-A71相关疾病发生呈现夏季和冬季两个高峰,主高峰集中在夏季(4~7月),次高峰集中在冬季(11~12月),以安慰剂组人群为主。所有EV-A71毒株与中国2007年以来其他省代表毒株相同,属于C4a亚型;各序列同源性较高,其核苷酸同源性为95.16%~100%,氨基酸同源性为96.94%~100%,与周边省市近3年序列亲缘关系较相近。结论 本研究安慰剂组人群中EV-A71除夏季流行外,在冬季仍有少量EV-A71的循环传播;EV-A71仍为C4a亚型且同源性较高,与周边省市的C4a亚型序列存在共同进化关系。 Objective To compare genetic characteristics of enterovirus A71(EV-A71) isolated from subjects receiving EV-A71 inactivated vaccine or placebo.Methods Using a 1-to-1 matched case-control design,the epidemiologic characteristics of diseases caused by EV-A71 were determined in both vaccine and placebo groups.All VP1 nucleotide sequences were analyzed with Sequencher 5.0 and MEG5.0 Software to compare molecular epidemiological characteristics between the two groups.Results 13 EV-A71 associated cases(0.3%) were reported in the vaccine group,and 106 cases(2.1%) were reported in the placebo group.The incidences of EV-A71 cases showed two epidemic peaks: a main one in summer(from April to July),and another in winter(from November to December), seen mainly in the control group.All EV-A71 strains in this study showed a high nucleotide homology with strains isolated since 2007 in other provinces in China;all were sub-genotype C4 a.A high degree of homology of nucleotides(95.16%-100%) and amino acids(96.94%-100%) was found among EVA71 strains in this study,and the closest phylogenetic relations were with sequences from nearby provinces.Conclusions EV-A71 circulated inthe placebo group during winter,following the summer epidemic.All EV-A71 strains in this study were sub-genotype C4 a and showed a high nucleotide homology with each other.The phylogenic tree showed that all strains in this study had coevolved with strains isolated in nearby provinces.
出处 《中国疫苗和免疫》 北大核心 2016年第1期1-5,9,共6页 Chinese Journal of Vaccines and Immunization
基金 国家重点基础研究发展计划(973计划)课题(编号:2011CB504902) 十二五国家科学技术艾滋病和病毒性肝炎等重大传染病防治专项-病毒性传染病病原谱流行规律及变异研究课题(编号:2013ZX10004-202) 自然疫源性传染病病原谱流行规律及变异研究课题(编号:2012ZX10004201-003)
关键词 肠道病毒A71型 肠道病毒A71型灭活疫苗 安慰剂 基因型 Enterovirus A71 Enterovirus A71 Inactivated Vaccine Placebo Genotype
  • 相关文献

参考文献19

  • 1Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system [J]. J Infect Dis, 1974, 129(3) :304-309.
  • 2VAN DER SANDEN S, KOOPMANS M, USLU G, et al. Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008 [J]. J Clin Microbiol, 2009, 47 : 2826-2833.
  • 3TAGAYA I, TAKAYAMA R, HAGIWARA A. A large scale epidemic of hand, foot and mouth disease associated with enterovirus 71 infection in Japan in 1978[J]. Japanese Journal of Medical Science & Biology, 1981, 34(3) : 191-196.
  • 4Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective chnical, virological, and molecular epidemiological study [J]. Clin Infect Dis, 2007,44 ( 5 ) : 646-656.
  • 5Samuda G M. Monoplegiacausedbyenterovirus71: an outbreak in Hong Kong[J]. Pediatr Infect Dis, 1987,6: 206-208.
  • 6LIU C C. An outbreak of enterovims 71 infection in Taiwan, 1998 : epidemiolngical and clinical manifestations [J]. J ClinVirol, 2000, 17(2) : 23-30.
  • 7Zhang Y, Zhu Z, Yang W, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China[J]. Virol J,2010,7:94.
  • 8WHO WPRO. A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth disease ( HFMD ). Available at: http ://www. wpro. who. int/publicatious/PUB _ 9789290615255/en/.
  • 9Zhu, F, Xu, W, Xia, J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China[J]. N Engl J Med, 2014, 370(9) :818-828.
  • 10中华人民共和国卫生部.手足口病预防控制指南[S].2009.

二级参考文献71

  • 1柯昌文,王珣章.人肠道病毒分类和鉴别方法研究进展[J].中国计划免疫,2006,12(6):515-520. 被引量:19
  • 2董晓楠,应剑,陈应华.1970~2004年全球肠道病毒71型分离株的分子流行病学分析[J].科学通报,2007,52(9):1021-1027. 被引量:108
  • 3ZHEN ZHU,WEN-BO XU,AI-QIANG XU,HAI-YAN WANG,YONG ZHANG,LI-ZHI SONG,Hui-LiYANG,YANLI,FENGJI.Molecular Epidemiological Analysis of Echovirus 19 Isolated From an Outbreak Associated With Hand, Foot, and Mouth Disease (HFMD) in Shandong Province of China[J].Biomedical and Environmental Sciences,2007,20(4):321-328. 被引量:22
  • 4[1]Oberste MS,Maher K,Kilpatrick DR,et al.Molecular evolution of the human enteroviruses:correlation of serotype with VP1 sequence and application to picornavirus classification[J].J Virol,1999,73(3):1941-1948.
  • 5[2]Schmidt NJ,Lennette EH,Ho HH.An apparently new enterovirus isolated from patients with disease of the central nervous system[J].J Infect Dis,1974,129(3):304-309.
  • 6[3]Blomberg J,Lycke E,Ahlfors K,et al.Letter:New enterovirus type associated with epidemic of aseptic meningitis and-or hand,foot,and mouth disease[J].Lancet,1974,2(7872)..112.
  • 7[4]Shindarov LM,Chumakov MP,Voroshilova MK,et al.Epidemiological,clinical,and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71[J].J Hyg Epidemiol Microbiol Immunol,1979,23 (3):284-295.
  • 8[5]Ishimaru Y,Nakano S,Yamaoka K,et al.Outbreaks of hand,foot,and mouth disease by enterovirus 71.High incidence of complication disorders of central nervous system[J].Arch Dis Child,1980,55(8):583-588.
  • 9[6]Nagy G,Takatsy S,Kukan E,et al.Virological diagnosis of enterovirus type 71 infections:experiences gained during an epidemic of acute CNS diseases in Hungary in 1978[J].Arch Virol,1982,71(3):217-227.
  • 10[7]Melnick J L,Schmidt NJ,Mirkovic RR,et al.Identification of Bulgarian strain 258 of enterovirus 71[J].Intervirology,1980,12(6):297-302.

共引文献377

同被引文献11

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部